Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis

Journal of the Neurological Sciences

Volumn 161, Issue 2, 1998, Pages 124-134

  Kleinschmidt DeMasters, B K ^a   Evans, Lynnette C ^a   Bitter, Mitchell A ^a   Shroyer, A Laurie ^b   Shroyer, Kenneth R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain; Central nervous system; Cerebrospinal fluid; Cytology; Meningeal carcinomatosis; Metastases; Prognosis; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CARCINOMATOUS MENINGITIS; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTODIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADULT; AGED; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TELOMERASE;

EID: 0032509135     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00254-8     Document Type: Article

References (40)

1. Axelrod N. Of telomeres and tumors. The enzyme, telomerase, may be switched on in tumor cells. Inhibitors of this enzyme might constitute a new class of anti-cancer drugs. Nat Med. 2:1996;158-159.
2. Balhuizen J., Bots G., Schabeg A.et al. Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg. 48:1978;747-753.
3. Bigner S.F., Johnston W.W. The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms. Acta Cytol. 25:1981;461-479.
4. Blasco M.A., Rizen M., Greider C.W., Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet. 12:1996;200-204.
5. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
6. Califano J., Ahrendt S., Meininger G., Westra W., Koch W., Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res. 56:1996;5720-5722.
7. Chadeneau C., Hay K., Hirte H.W., Gallinger S., Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:1995;2533-2536.
8. Counter C., Hirte H.W., Bacchette S., Harley C.B. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 91:1994;2900-2904.
9. Cunningham V., Markham N., Shroyer A., Shroyer K. Detection of telomerase expression in fine needle aspirations and fluids. Diagn Cytopathol. 18:1998;1-6.
10. DeMasters B.K., Hashizumi T., Sze C., Lillehei K.O., Shroyer A.L., Shroyer K.R. Differences in telomerase expression between multiple regions of oligodendroglioma and high grade astrocytoma: correlation with Mib-1 labeling. J Clin Pathol. 51:1998;284-293.
11. DeMasters B.K., Markham N., Lillehei K.O., Shroyer K.R. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol. 107:1997;548-554.
12. DeMasters B., Shroyer A., Hashizumi T.et al. Telomerase levels in human metastatic brain tumors show four-fold logarithmic variability but no correlation with tumor type or interval to patient demise. J Neurol Sci. 161:1998;116-123.
13. DeMay RM. Cerebrospinal fluid. In: The Art and science of cytopathology, exfoliative cytology. Chicago: ASCP Press, 1996:438.
14. Gorham H., Yoshida K., Sugino T.et al. Telomerase activity in human gynaecological malignancies. J Clin Pathol. 50:1997;501-504.
15. Greider C.W., Blackburn E.H. Telomeres, telomerase and cancer. Scientific American. 274:1996;92-97.
16. Healy K.C. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res. 7:1995;121-130.
17. Hiyama E., Gollahon L., Kataoka T.et al. Telomerase activity in human breast tumors. J Natl Cancer Inst. 88:1996;116-122.
18. Hiyama K., Hiyama E., Ishioka S.et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst. 87:1995;895-902.
19. Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszed M.A., Shay J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1:1995;249-255.
20. Hiyama E., Kodama T., Shinbara K.et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res. 57:1997;326-331.
21. Hiyama E., Yokoyama T., Tatsumoto N.et al. Telomerase activity in gastric cancer. Cancer Res. 55:1995;3258-3262.
22. Holliday R. Endless quest. Bio Essays. 18:1996;3-5.
23. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
24. Kinoshita H., Ogawa O., Kakehi Y.et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst. 89:1997;724-730.
25. Kyo S., Takakura M., Ishikawa H.et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res. 57:1997;1863-1867.
26. Nakatani K., Yoshimi N., Mori H., Yoshimura S., Sakai H., Shinoda J.et al. The significant role of telomerase activity in human brain tumors. Cancer. 80:1997;471-476.
27. Nelder J.A., Wedderbum R.W.M. Generalized linear models. J R Stat Soc. 135:1972;370-384.
28. Nouso K., Urabe Y., Higashi T.et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer. 78:1996;232-236.
29. Parkinson E.K. Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer. 73:1996;1-4.
30. Sharma H.W., Maltese J.Y., Zhu X., Kaiser H.E., Narayanan R. Telomeres, telomerase and cancer: Is the magic bullet real? Anticancer Res. 16:1996;511-516.
31. Sharma H.W., Sokoloski J.A., Perez J.R., Maltese J.Y., Sartorelli A.C., Stein C.A.et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA. 92:1996;12343-12346.
32. Shay J., Gazdar A. Telomerase in the early detection of cancer. J Clin Pathol. 50:1997;106-109.
33. Shroyer K.R., Stephens J.K., Silverberg S.G., Markham N., Shroyer A.L., Wilson M.et al. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma. Int J Gynecol Pathol. 16:1997;225-232.
34. Sommerfelt H.J., Meeker A.K., Piatyszed M.A., Bova G.S., Shay J.W., Coffey C.S. Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res. 56:1996;218-222.
35. Sugino T., Yoshida K., Bolodeoku J.et al. Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer. 69:1996;301-306.
36. Wright W.E., Shay J.W., Piatyszed M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:1995;3794-3795.
37. Yang S., Lee D., Hong S., Chung B., Kim I. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washings. Yonsei Med J. 38:1997;155-159.
38. Yoshida K., Sugino T., Goodison S.et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 75:1997;548-553.
39. Yoshida K., Sugino T., Tahara H.et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 79:1997;362-369.
40. Zheng P., Iwasaka T., Yokoyama M., Nakao Y., Pater A., Sugimori H. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol. 66:1997;222-226.